Cytolytic virus activation therapy for epstein-barr virus-driven tumors

M.A. Wildeman, Z. Novalic, S.A.W.M. Verkuijlen, H. Juwana, A.D.R. Huitema, I.B. Tan, J.M. Middeldorp, J.P. de Boer, A.E. Greijer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)5061-5070
JournalClinical Cancer Research
Volume18
Issue number18
DOIs
Publication statusPublished - 2012

Cite this

Wildeman, M. A., Novalic, Z., Verkuijlen, S. A. W. M., Juwana, H., Huitema, A. D. R., Tan, I. B., ... Greijer, A. E. (2012). Cytolytic virus activation therapy for epstein-barr virus-driven tumors. Clinical Cancer Research, 18(18), 5061-5070. https://doi.org/10.1158/1078-0432.CCR-12-0574
Wildeman, M.A. ; Novalic, Z. ; Verkuijlen, S.A.W.M. ; Juwana, H. ; Huitema, A.D.R. ; Tan, I.B. ; Middeldorp, J.M. ; de Boer, J.P. ; Greijer, A.E. / Cytolytic virus activation therapy for epstein-barr virus-driven tumors. In: Clinical Cancer Research. 2012 ; Vol. 18, No. 18. pp. 5061-5070.
@article{1fe854bd55bf4ecbb6698a106430b13a,
title = "Cytolytic virus activation therapy for epstein-barr virus-driven tumors",
author = "M.A. Wildeman and Z. Novalic and S.A.W.M. Verkuijlen and H. Juwana and A.D.R. Huitema and I.B. Tan and J.M. Middeldorp and {de Boer}, J.P. and A.E. Greijer",
year = "2012",
doi = "10.1158/1078-0432.CCR-12-0574",
language = "Undefined/Unknown",
volume = "18",
pages = "5061--5070",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

Wildeman, MA, Novalic, Z, Verkuijlen, SAWM, Juwana, H, Huitema, ADR, Tan, IB, Middeldorp, JM, de Boer, JP & Greijer, AE 2012, 'Cytolytic virus activation therapy for epstein-barr virus-driven tumors' Clinical Cancer Research, vol. 18, no. 18, pp. 5061-5070. https://doi.org/10.1158/1078-0432.CCR-12-0574

Cytolytic virus activation therapy for epstein-barr virus-driven tumors. / Wildeman, M.A.; Novalic, Z.; Verkuijlen, S.A.W.M.; Juwana, H.; Huitema, A.D.R.; Tan, I.B.; Middeldorp, J.M.; de Boer, J.P.; Greijer, A.E.

In: Clinical Cancer Research, Vol. 18, No. 18, 2012, p. 5061-5070.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Cytolytic virus activation therapy for epstein-barr virus-driven tumors

AU - Wildeman, M.A.

AU - Novalic, Z.

AU - Verkuijlen, S.A.W.M.

AU - Juwana, H.

AU - Huitema, A.D.R.

AU - Tan, I.B.

AU - Middeldorp, J.M.

AU - de Boer, J.P.

AU - Greijer, A.E.

PY - 2012

Y1 - 2012

U2 - 10.1158/1078-0432.CCR-12-0574

DO - 10.1158/1078-0432.CCR-12-0574

M3 - Article

VL - 18

SP - 5061

EP - 5070

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 18

ER -

Wildeman MA, Novalic Z, Verkuijlen SAWM, Juwana H, Huitema ADR, Tan IB et al. Cytolytic virus activation therapy for epstein-barr virus-driven tumors. Clinical Cancer Research. 2012;18(18):5061-5070. https://doi.org/10.1158/1078-0432.CCR-12-0574